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Abstract 14 
Advanced glycation end products (AGEs) play an important role in the onset of diabetic 15 
retinopathy. Therefore, in the current study, we investigate whether and how Tanshinone IIa 16 
(Tan IIa) from Salvia miltiorrhiza protects bovine retinal endothelial cells (BRECs) against 17 
methylglyoxal (MGO) mediated cell dysfunction. The results showed that MGO reduced cell 18 
viability in dose dependent manner. The treatment of Tan IIa (50 µM) significantly improved cell 19 
viability induced by MGO in BRECs.  MGO increased cellular reactive oxygen species formation 20 
and cellular nitric oxide (NO) level; enhanced nox1 and iNOS mRNA levels; inhibited prdx1 21 
mRNA level. The treatment of Tan IIa effectually ameliorated cellular oxidative stress. Exposure 22 
of MGO resulted in mitochondrial fission and decrease of opa1 and mfn1. No significant 23 
difference in mRNA levels of mfn2 and drp1 was detected between MGO and medium. Tan IIa 24 
reduced mitochondrial fragmentation, enhanced the mRNA levels of mfn1 and opa1 in MGO 25 
cultured BRECs. The short time exposure of cellular antioxidatants, dimethylthiourea (10mM) 26 
and tiron (10mM) had no effect on mitochondrial fission although they ameliorated cellular 27 
reactive oxygen species level. Moreover, overexpression of GLO1 increased key proteins of 28 
mitochondrial fusion, including OPA1 and MFN1 in BRECs cultured with MGO. However, 29 
inhibition of GLO1 by siRNA abolished the effect of Tan IIa on induction of mitochondrial fusion 30 
in MGO cultured BRECs. In conclusion, MGO caused the injury of retinal endothelial cells 31 
through induction of mitochondrial dysfunction and mitochondrial fission, the treatment of Tan 32 
IIa ameliorated mitochondrial dysfunction and fission induced by AGEs through enhancing 33 
GLO1. 34 
Keywords: Taninone IIa, glycation, glyoxalase I, mitochondrial fission  35 
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1. Introduction  36 
Retinopathy is one of major chronic micro-vascular complications in diabetes. Accumulation of 37 
advance glycation end products (AGEs) play an important role in the development of diabetic 38 
retinopathy (DR) (Feener and King, 1997). The initial formation of cellular AGEs is mainly from 39 
non-enzymatic reaction of glucose and the reactive dicarbonyl metabolites of glucose, including 40 
methylglyoxal (MGO) (Brownlee, 1995; Feener and King, 1997; Vlassara and Uribarri, 2014). 41 
The increase of AGEs leads to up-regulate VEGF expression (Deissler et al., 2014), and 42 
stimulates the secretion of pro-inflammatory cytokines (Nakamura et al., 2003), which increase 43 
vascular permeability leaking and leukocyte aggregation in the retinal microvasculature (Otero 44 
et al., 2001). Excessive MGO leads to accumulation of lipofuscin in RPE and inhibition of RPE 45 
cell proliferation (Yoon et al., 2012). Plenty of evidences reveal that cellular oxidative stress and 46 
mitochondrial dysfunction induced by AGEs trigger and deteriorate retinal dysfunction in 47 
diabetes (Roy et al., 2017). In diabetic renal microvascular endothelial cells, mitochondrial 48 
electron chain transporter complex III is impaired though the modification of arginine residues of 49 
cytochrome C1 by MGO (Rosca et al., 2005). Besides that, oxidative stress increases 50 
mitochondrial membrane permeability by opening mitochondrial inner membrane pores and 51 
reducing membrane potential in diabetic cardiac myocytes (Van Remmen et al., 2001). In 52 
pancreatic beta cells, exposure of glycated modification of bovine serum albumin (BSA) results 53 
in the decrease of insulin secretin and defect of mitochondrial formation. Exposure of glycated-54 
BSA increases mitochondrial damage and Drp1 expression (Lo et al., 2015). Yu et al. have 55 
reported that inhibition of AGEs receptor reduces mitochondrial fission in cardiomyocytes from 56 
high fat diet induced obesity (Yu et al., 2017). However, the link between cellular oxidative 57 
stress and mitochondrial dynamics induced by glycated modification in retinal endothelial cells is 58 
unclear.  59 
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S. miltiorrhiza is widely used as a supplementary medicine in China, Korea and Japan. It has 60 
been applied in the treatment of cardiovascular diseases and cerebrovascular diseases (Wang 61 
et al., 2018). Tanshinones IIa (Tan IIa) is one of main lipophilic components from S. miltiorrhiza 62 
(Gao et al., 2018). Tan IIa reduces VEGF secretion in human retinal pigment epithelial cells 63 
(APRE19 cells) under hypoxic condition (Alzhrani et al., 2017). In human retinal endothelial cells, 64 
Tan IIa inhibits VEGF and ICAM1 mRNA levels in 25 mM glucose condition (Fan et al., 2017). 65 
Tan IIa ameliorates mitochondrial membrane potential and mitochondrial permeability transition 66 
in model of neuron and liver damage (Liu et al., 2010; Zhu et al., 2010).  However, the 67 
regulation of retinal mitochondrial fusion and fission by Tan IIa is not clear yet. 68 
Therefore, in the current study, we explore whether Tan IIa protects retinal endothelial cell 69 
against MGO mediated mitochondrial dysfunction and mitochondrial fission. We also investigate 70 
the mechanism that mediates mitochondrial dynamics under cellular glycated modification 71 
condition, particularly focus on the link between mitochondrial reactive oxygen species 72 
formation and mitochondrial fission induced by MGO.  73 
 74 
 75 
  76 
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2. Materials and Methods 77 
2.1 Materials 78 
Tanshinone IIa (chemical structure as Fig. 1) was purchased from National Institute for the 79 
Control of Pharmaceutical and Biological Products, China. Collagenase IV, fibronectin, crystal 80 
violet were from Sigma USA. CM-2',7'-dichlorodihydrofluorescein diacetate (H2DCFDA), 4-81 
Amino-5-Methylamino-2',7'-Difluorofluorescein Diacetate (DAF-FM), 5, 5′, 6, 6′-tetrachloro1, 1′, 3, 82 
3′-tetraethyl-benzimidazolylcarbocyanine iodide (JC-1), Mitotracker red, Lipofectamine 83 
RNAiMax® Transfection Reagent, Lipofectamine 2000 Transfection reagent, Opti-MEM 1 84 
medium were from Life Technologies, USA. MGO was from Yuecheng Biotechnology, China. 85 
GSH was from Kyowa, Japan. Trizol reagent was from Chengdu Yuqiang Technology Co. Ltd, 86 
China. SYBR Green master mix was from MedChemExpress, China.  87 
2.2 Cell culture  88 
Bovine eyes were from local slaughtering house, the isolation and culture of retinal endothelial 89 
cells was followed the protocol described by Caperandes A, et al (Capetandes and Gerritsen, 90 
1990). Briefly, bovine retina was collected and homogenized. After collagenase IV digestion, 91 
cells were seeded to fibronectin (Sigma)-coated dishes. Bovine retinal endothelial cells (BREC) 92 
were used in current study after four or five passages.  93 
2.3 Transient knockdown of glyoxalase I expression by RNAi 94 
BREC cells were seeded into 6-well or 96-well plate. After reaching 80% confluence, cells were 95 
transfected with GLOI or non-specific scrambled siRNAs using Lipofectamine RNAiMax® 96 
according to the manufacturer's instructions in serum-free OptiMEM® media. After incubation 97 
with transfection complexes for 6 h, the medium was changed to antibiotic-free media. The 98 
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double stranded siRNA sequences against bovine GLO RNAi were 5’' CAG GAA AUC AUG 99 
UGA UUC AAG AUAT 3' and 5’ AUA UCU UGA AUC ACA UGA UUU CCU GUU 3'.  100 
2.4 Transient overexpression of glyoxalase I expression 101 
BREC cells were seeded into 6-well or 96-well plates. After reaching 80% confluence, cells 102 
were transfected with GLOI vector and pcDNA3 using Lipofectamine 2000 according to the 103 
manufacturer's instructions in serum-free OptiMEM® media. After incubation with transfection 104 
complexes for 4.5 h, the medium was changed to complete growth media. 105 
2.5 Cell viability using crystal violet assay 106 
BREC cells were seeded in 96-well plates and treated with different conditions. Cells were fixed 107 
with 4% formaldehyde solution and stained nuclei with 0.2% crystal violet solution. 1% SDS 108 
solution was added to dissolve the staining particle, the absorbance of each well was obtained 109 
at 570 nm.  110 
2.6 Glyoxalase 1 activity and GSH level 111 
The measurement of glyoxalase 1 activity was followed the protocol described by McLellan AC, 112 
et al (McLellan and Thornalley, 1989). BREC cells were seeded to 6-well plates. Cellular lysate 113 
was added to hemithioacetal, prepared by pre‐incubating MGO and GSH. The standard assay 114 
mixture contained 2 mm MGO and 2 mm GSH in a sodium phosphate buffer (100 mm, pH 6.6, 115 
37 °C). GSH level was determined according to the manual described by commercial supplier, 116 
Nanjing Jiancheng Bioengineering Institute.   117 
2.7 Measurement of cellular reactive oxygen species and NO levels 118 
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reactive oxygen species was determined using CM-H2DCFDA, and NO was measured by DAF-119 
FM. BREC cells were seeded to 96-well black plates with clear bottom. Cells were treated with 120 
100 µM MGO with or without Tan IIa for 24 h. At the end of the experimental treatments, cells 121 
were washed with PBS and loaded with probe, and incubated at 37°C for 10 min followed by a 122 
PBS wash.  123 
2.8 Measurement of mitochondrial membrane potential (∆ψm) 124 
Mitochondrial membrane potential was measured by JC-1. JC-1, a cationic dye, exhibits 125 
mitochondrial membrane potential-dependent aggregation detected as fluorescent aggregates 126 
(red). Loss of mitochondrial membrane potential causes JC-1 to shift to monomeric for (green). 127 
A decrease in red/green ratio is interpreted as a loss of mitochondrial membrane potential. After 128 
treatment, BREC cells were incubated with JC-1 dye for 45 min at 37°C. The ratio of aggregate 129 
(red) and monomer (green) is an indication of mitochondrial membrane potential. 130 
2.9 Mitochondrial morphology 131 
BREC cells were seeded in 96-well plates. Mitotracker red was used to stain mitochondria 132 
following the described by manufacturer. Cells were treated with 100 µM MGO with/without 133 
Tanshinone IIa for 24 h. Images were taken by confocal microscopy. All images were acquired 134 
using a 40X oil immersion objective. 135 
2.10 Realtime RT-PCR 136 
BREC cells were seeded in 12-well plates. After the designed treatment, RNA was extracted by 137 
Trizol. Quantity PCR was performed using the SYBR Green master mix.  Primers: glo1 forward 138 
primer: 5’-CGG CTT TGG AGG CTT GAG TA-3’, reverse primer: 5’-AAC ACA AGC ACC ACT 139 
TGC AC-3’; beta actin forward primer: 5’- CAG TCG GTT GGA TCG AGC AT-3’ reverse primer: 140 
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5’- TGG CTT TTG GGA AGG CAA AG-3’; inos forward primer: 5’-GGT GGA AGC AGT AAC 141 
AAA GGA-3’, reverse primer: 5’-GAC CTG ATG TTG CCG TTG TTG-3’; prdx1 forward primer: 142 
5’- TGG TGT CGG TCC TAT TTC AGT G-3’, reverse primer: 5’- GCT GTT GCT TTG AAC TGG 143 
GG-3’; nox1 forward primer: 5’- CTC TGC TCG CTG CTT GAA TTT-3’ reverse primer: 5’- GTG 144 
GAA GGC GAG GTT GTG AT-3’;  drp1 forward primer: 5’-ACG AGT TAT GGA GGC GCT AA-145 
3’, reverse primer: 5’-AGC TCT TTC CAC TGC TCT GC-3’; mfn1 forward primer: 5’-TGC ACC 146 
AAT GAA GTC AAC GC-3’, reverse primer: 5’-TGC AAG GAA CCA GTG TGT GT-3’; mfn2 147 
forward primer: 5’-CAA GAG TCA GTA ACT CAG AAT TGG T-3’, reverse primer: 5’-GTC TGC 148 
TGG TAC AAC TGG AAC-3’; opa1 forward primer: 5’-CCT TGC AAA ATT GGC ACC TGA-3’, 149 
reverse primer: 5’-CCA GGT GAA CCT GTG GTG AA-3’;  150 
2.11 Data Analysis and Statistics 151 
The results were analyzed for statistical significance by GraphPad Prism software (GraphPad 152 
Software) using ANOVA test with Tukey post hoc test or Mann-Whitney for comparisons 153 
wherever appropriate. The results were shown as Mean ± S.E.M. and differences between 154 
means were considered statistically significant when p<0.05.  155 
 156 
  157 
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3. Results 158 
3.1 Tan IIa rescued cell death induced by MGO in primary bovine retinal endothelial cells  159 
The results showed that exposure with MGO led to a reduction of cell viability in dose 160 
dependent manner (Fig. 2A). 10 µM MGO significantly decreased cell viability in comparison 161 
with medium (P<0.05). The treatment of 50 µM Tan IIa, not 10 µM, significantly improved the 162 
reduction of cell viability by MGO in BRECs (P<0.01, Fig. 2B). Furthermore, 50 µM Tan IIa 163 
improved GLO1 activity and mRNA level in MGO cultured with BRECs (Fig. 2C and Fig. 2D). In 164 
the meantime, Fig. 2E showed that the treatment of Tan IIa ameliorated the reduction of GSH in 165 
MGO conditions (P<0.01). In summary, increase of general glycated modification by MGO 166 
resulted in reduction of cell viability and inhibition of GLO1 mRNA, the treatment of Tan IIa 167 
protected retinal endothelial cells against cellular impairs induced by MGO.   168 
3.2 Tan IIa rescued cellular oxidative stress induced by MGO in primary bovine retinal 169 
endothelial cells 170 
It is known that oxidative stress plays a crucial role in endothelial dysfunction induced by MGO. 171 
We monitored cellular oxidative stress level using fluorescent probe H2DCFDA. Results of Fig. 172 
3A revealed that 100 µM MGO markedly enhanced cellular oxidative stress, compared with 173 
vehicle (P<0.005). The treatment of Tan IIa ameliorated the induction of oxidative stress in 174 
MGO (P<0.005). Furthermore, results of Fig. 3B and Fig. 3C showed that MGO caused the 175 
significant reduction of prdx1 mRNA and increase of nox1 mRNA. The treatment of Tan IIa 176 
significantly improved pdrx1 mRNA level (P<0.01), and reduced nox1 mRNA in MGO cultured 177 
BRECs (P<0.05). Moreover, Fig. 3D and Fig. 3E displayed that MGO also stimulated cellular 178 
nitic oxide (NO) level and iNOS mRNA level in comparison with vehicle. Tan IIa ameliorated 179 
cellular NO level (P<0.005) and reduced iNOS mRNA (P<0.001), compared with MGO. In 180 
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conclusion, excessive MGO increased cellular oxidative stress, administration of Tan IIa 181 
ameliorated oxidative stress through the increase of antioxidant enzyme and inhibition of 182 
oxidative enzymes.  183 
3.3 Tan IIa inhibited mitochondrial fission induced by MGO in primary bovine retinal endothelial 184 
cells 185 
Mitochondria are key cellular organelles of producing ATP. Electron gradient driven membrane 186 
potential is crucial for ATP generation and mitochondrial dynamics. Reduction of mitochondrial 187 
membrane potential results in low OPA1 level, therefore, leads to mitochondrial fission. Here, 188 
we used JC-1 as the probe to detect mitochondrial membrane potential. Fig. 4A showed the 189 
level of mitochondrial membrane potential decreased markedly after exposure with excessive 190 
MGO. The treatment of Tan IIa increased significantly the level of mitochondrial membrane 191 
potential in BREC cells with MGO (P<0.05).  192 
MitoTracker Red was added to BREC cells to observe mitochondrial morphology using 193 
fluorescent confocal microscopy. Fig. 4B and Fig. 4C showed MGO led to an increase of 194 
mitochondrial fragmentation in comparison with medium. The treatment of Tan IIa reversed 195 
mitochondrial fragmentation. The results of Fig. 4D, Fig. 4E, Fig. 4F and Fig. 4G displayed that 196 
MGO reduced the expression of OPA1 and MFN1, the key proteins of mitochondrial fusion, 197 
comparing with medium (P<0.005). The treatment of Tan IIa significantly restored the reduction 198 
of OPA1 (P<0.05) and MFN1 (P<0.005) mRNA levels (Fig. 4C and Fig 4D). However, there was 199 
no significant difference in mRNA level of MFN2 (one of the key protein of mitochondrial fusion) 200 
and drp1 (the key protein of mitochondrial fission) among vehicle, MGO and MGO plus Tan IIa 201 
treatment (Fig. 4E and 4F). In summary, the results revealed that the MGO inhibited OPA1 and 202 
MFN1 mRNA levels and induced mitochondrial fission. The treatment of Tan IIa reduced 203 
mitochondrial fission induced by accumulation of MGO in BRECs.  204 
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3.4 Short-term amelioration of cellular oxidative stress had no effect on mitochondrial fission 205 
induced by MGO 206 
The current results indicated that excessive cellular MGO led to increase of cellular oxidative 207 
stress and mitochondrial fission. Therefore, in this section, we will explore whether cellular 208 
oxidative stress contribute to mitochondrial fission induced by MGO. Fig. 5A showed that, 30 209 
min treatment of dimethylthiourea (10mM) and tiron (10mM) significantly ameliorated cellular 210 
reactive oxygen species level (P<0.005). However, 30 min treatment of dimethylthiourea and 211 
tiron had no significant effect on OPA1, MFN1 and drp1 mRNA levels (Fig. 5B, Fig. 5C and Fig. 212 
5D). In summary, the results revealed indirectly that the induction of mitochondrial fission by 213 
MGO may be due to the glycated modification of key proteins involved in mitochondrial fusion 214 
process.  215 
3.5 Overexpression of glyoxalase I improved the mRNA levels of mitochondrial fusion related to 216 
gene in MGO cultured BREC cells 217 
According to the glycated prediction analysis from website 218 
(http://www.cbs.dtu.dk/services/NetGlycate/), OPA1 and MFN1 have multiple glycated sites 219 
(supplemental Fig.). We used western blot to test AGEs using commercial anti-methylglyoxal 220 
antibody, no difference was detected between MGO and medium (data were not shown). The 221 
reason may be due to that antibody has no cross reaction with bovine. As it is known that GLO1 222 
is the key enzyme detoxifying reactive dicarbonyls (Jack and Wright, 2012). Therefore, in this 223 
section, overexpression of GLO1 was used to reduce of protein glycated modification by MGO. 224 
Results of Fig. 6  confirmed that overexpression of GLO1 increased GLO1 activity compared 225 
with pcDNA (P<0.01). Data from Fig. 6B showed that overexpression of GLO1 improved cell 226 
viability induced by MGO (P<0.05). Fig. 6C and Fig. 6D showed that overexpression of GLO1 227 
increased the mRNA levels of MFN1 and OPA1. In summary, those results indirectly revealed 228 
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that the improvement of mitochondrial fission by overexpression of GLO1 is though reduction of 229 
protein glycated modification.  230 
3.6 Inhibition of GLO1 blocked the therapeutic effect of Tan IIa on MGO cultured BRECs 231 
To explore whether the effect of Tan IIa is through GLO1, GLO1 expression was inhibited by 232 
transiently transfected with GLO1 siRNA. The results of Fig. 7A confirmed that GLO1 mRNA 233 
levels markedly inhibited after BRECs were transfected with GLO1 siRNA, compared with 234 
scramble siRNA (P<0.005). Fig. 7B showed that inhibition of GLO1 expression by siRNA 235 
deteriorated significantly cellular reactive oxygen species formation induced by MGO (P<0.01). 236 
Furthermore, the treatment of Tan IIa did not ameliorate cellular reactive oxygen species 237 
formation induced by MGO after inhibition of GLO1 expression. Fig. 7C and Fig. 7D further 238 
demonstrated that the effect of Tan IIa on the induction of opa1 and mfn1 mRNA reduced after 239 
inhibition of GLO1 by siRNA (P<0.05). In summary, all of those data revealed indirectly that the 240 
effect of Tan IIa on amelioration of cellular reactive oxygen species formation and mitochondrial 241 
fission was through GLO1.  242 
  243 
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4. Discussion 244 
In current study, our results revealed that Tan IIa protected retinal endothelial cells against 245 
mitochondrial fission induced by MGO through the improvement of protein glycated modification. 246 
It is known that glycation is one of major causes of chronic microvascular endothelium 247 
dysfunction, which shows increase of oxidative stress, endothelium leaking. The importance of 248 
MGO on the development of vascular endothelium dysfunction has been explored extensively. 249 
Exposure of MGO leads to loss of endothelial cells, basement membrane thickening, luminal 250 
occlusion (Berlanga et al., 2005) and oxidative stress (Sena et al., 2012). Furthermore, in vitro 251 
study mimicking hyperglycemia condition, overexpression of GLO1 ameliorates the impairment 252 
of formation of tube-like structures, and reduces AGE formation in diabetic rats (Brouwers et al., 253 
2014). The mechanism that mediates glycation induced retinal endothelium dysfunction is not 254 
fully clear yet. Our results demonstrated that excessive MGO reduced cell viability in dose 255 
dependent manner in BRECs. 100 µM MGO increased cellular reactive oxygen species 256 
formation and cytosol oxidative enzyme, NOX1 mRNA level; decreased cellular anti-oxidative 257 
enzymes, prdx1 mRNA levels. Besides those, MGO also enhanced chronic inflammation and 258 
impairs endothelial cell integrates (McVicar et al., 2015; Wang et al., 2014). Tan IIa has been 259 
used in the treatment of cardiovascular disease and nephropathy (Li et al., 2018; Liang et al., 260 
2018; Yan et al., 2018). Tan IIa markedly inhibited diabetes induced proliferation, migration and 261 
vascularization in human retinal endothelial cells (Fan et al., 2017), and inflammation in human 262 
pigment endothelial cells (Lee et al., 2015). Chen X, et al. revealed that the treatment of Tan IIa 263 
markedly improved diabetic nephropathy through enhancing SOD activity and reducing MDA 264 
level (Chen et al., 2017). The results from BRECs confirmed that the treatment of 50 µM Tan IIa 265 
rescued the reduction of cell viability, ameliorated the induction of general cellular oxidative 266 
stress, inhibited NOX1 mRNA level and increased sirt1 and pdrx1 mRNA levels in BRECs 267 
exposed with excess MGO.  268 
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Mitochondria is the key organelle of generating cellular oxidative stress. It is known that 269 
mitochondria constantly produce reactive oxygen species during oxidative phosphorylation. 270 
Endogenous protective system, such as unfolded proteins and anti-oxidative enzymes, can 271 
maintain normal mitochondrial function (Baker et al., 2011; Nargund et al., 2012). However, 272 
defective mitochondria may impair cellular function through generating excessive reactive 273 
oxygen species formation and needs to be eliminated from mitochondrial network. Mitochondrial 274 
inner fusion protein OPA1 is inactivated by inner membrane protease OMA1, which leads to 275 
significant decrease of mitochondrial membrane potential (Ehses et al., 2009; Head et al., 2009). 276 
In the meantime, the outer membrane fusion proteins, MFN1 and MFN2 are ubiquitinated. 277 
Modified MFN1 and MFN2 are binding to p97 and then degraded by proteasomes (Tanaka et al., 278 
2010). When modified proteins were expended to the whole mitochondrial membrane, 279 
mitochondrial fission is induced by activation of Drp1. Mid49, Mid51 and  mitochondrial fission 280 
factor are necessary for recruiting Drp1 to mitochondria membrane (Elgass et al., 2013). 281 
Mitochondrial fission leads to lower mitochondrial membrane potential. Our results revealed that 282 
100 µM MGO caused significant decrease of mitochondrial membrane potential, and increased 283 
mitochondrial fragment and decreased MFN1 and OPA1 mRNA levels. The treatment of Tan IIa 284 
inhibited mitochondrial fragment, enhanced the MFN1 and OPA1 mRNA level. In summary, the 285 
treatment of Tan IIa can protect retinal endothelial cells against cellular oxidative stress and 286 
mitochondrial fission induced by excessive MGO. 287 
It is known that cellular excessive reactive oxygen species formation results in mitochondrial 288 
fission, and increase of apoptosis (Wu et al., 2011; Youle and van der Bliek, 2012). Therefore, 289 
in current study, we investigated whether mitochondrial fission induced by excessive MGO was 290 
through cellular oxidative stress. Short term exposure of anti-oxidant (dimethylthiourea and tiron) 291 
markedly ameliorated mitochondrial reactive oxygen species formation induced by MGO. 292 
However, the treatment of dimethylthiourea and tiron did not alter mRNA levels of MFN1 and 293 
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OPA1. Those results suggest that general cellular glycated modification may play a crucial role 294 
in the induction of mitochondrial fission in BRECs. According to bioinformatics analysis from 295 
NetGlycate, both of OPA1 and MFN1 can be glycated modification (suppl Fig.). However, we 296 
did not have direct evidence to confirm the bioinformatics analysis (data from western blot was 297 
unable to detect the difference between control and MGO cultured BRECs. Images of western 298 
blot did not show). The indirect experiment (GLO1 overexpression) was applied in this study. It 299 
is well-known that GLO1 is the key enzyme to detoxify MGO (Xue et al., 2008). Imbalance of 300 
MGO and GLO1 generates chronic vascular dysfunction, insulin resistance, ageing and 301 
atherosclerosis (Navarrete Santos et al., 2017; Nigro et al., 2017; Petrie et al., 2018). Our 302 
results demonstrated that overexpression of GLO1 increased GLO1 and rescued the reduction 303 
of OPA1 and MFN1 mRNA by 100 µM MGO. Our results from GLO1 siRNA further revealed 304 
that inhibition of GLO1 by siRNA markedly deteriorated mitochondrial reactive oxygen species 305 
formation and mitochondrial fusion related proteins, including OPA1 and MFN1. The effect of 306 
Tan IIa on amelioration of cellular reactive oxygen species formation and stimulation of opa1 307 
and mfn1 mRNA was abolished after GLO1 expression was blocked by GLO1 siRNA.   308 
In conclusion, the current study showed that the treatment of Tan IIa protected primary retinal 309 
endothelial cells against cellular oxidative stress and reduction of mitochondrial fission. The 310 
mechanism that mediated improvement of mitochondrial fission is though improvement of 311 
general cellular glycated modification. The further investigation of therapeutic effect of Tan IIa 312 
on diabetic retinopathy needs to explore in vivo research. 313 
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Figure Legends 456 
Figure 1. Chemical structure of Tan IIa 457 
Figure 2. Tan IIa rescued cellular death led by cellular glycation. a. Cell viability was 458 
determined by crystal violet assay after exposure with MGO for 24 h. MGO reduced cell viability 459 
in dose dependent manner. * P<0.05, **P<0.01 and *** P<0.005 compared with medium. b. 460 
Crystal violet assay showed the protective effect of Tan IIa. 10 and 50 µM Tan IIa increased cell 461 
viability under the condition of 100 µM MGO. ** P<0.01 compared with 100 µM MGO. c. GLO1 462 
activity was determined in BRECs. Experimental conditions were: medium, 100 µM MGO, 50 463 
µM Tan IIa and 100 µM MGO plus 50 µM Tan IIa for 24 h. # P<0.05 compared with 100 µM 464 
MGO. d. GLO1 mRNA level decreased after exposure with MGO for 24 h. The treatment of 50 465 
µM improved GLO1 mRNA level, *P<0.05, compared with MGO. e. GSH level was monitored in 466 
BRECs under different experimental conditions. **P<0.01 indicates significant difference 467 
compared with MGO. 468 
Figure 3. The treatment of Tan IIa ameliorated oxidative stress induced by cellular 469 
glycated modification. a. Cellular reactive oxygen species formation was measured by 470 
fluorescent probe, CM-H2DCFDA. *** P<0.005 compared with medium. ### P<0.005 compared 471 
with MGO. b. prdx1 c. nox1 mRNA levels were determined using Bio-Rad SYBR green 472 
supermix kit. **P<0.01 indicates significant difference compared with medium, and ## P<0.01 473 
indicates statistical significance compared with MGO. d. Cellular NO level was measured by 474 
DAF-FM. *** P<0.005 compared with medium. ### P<0.005 compared with MGO. e. iNOS 475 
mRNA levels were determined using Bio-Rad SYBR green supermix kit. *** P<0.005 indicates 476 
significant difference compared with medium, and ## P<0.01 indicates statistical significance 477 
compared with MGO. 478 
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Figure 4. Tan IIa rescued mitochondrial fission induced by MGO. a. JC-1 was used to 479 
measure mitochondrial membrane potential. The experiments repeated 3 times.  Data are 480 
shown as means ± S.E.M.. *** P<0.005 indicates statistically significant difference relative to 481 
medium, and # P<0.05 indicates statistical significance related to 100 µM MGO. b. 482 
Representative confocal images (63X) of mitochondrial morphology in BRECs. Mitochondria 483 
were stained by mitotracker red. c. Cells with fragmented mitochondria were counted under a 484 
confocal microscope. *** P<0.005 compared with medium; ## P<0.01 compared with 100 µM 485 
MGO. d. OPA1 e. MFN1 f. MFN2 and g. Drp1 mRNA levels were determined by realtime RT-486 
PCR. *** P<0.005 indicates statistically significant difference relative to medium, and # P<0.05, 487 
## P<0.01 indicates statistical significance related to 100 µM MGO.  488 
Figure 5. Short-term amelioration of cellular oxidative stress had no effect on 489 
mitochondrial fission induced by MGO in BRECs. a. cellular reactive oxygen species 490 
formation was evaluated as described above. Data are shown as means ± S.E.M. as 491 
determined. *** P<0.005 indicates statistically significant difference relative to medium. ### 492 
P<0.005 indicates statistically significant difference relative to 100 µM MGO. b. OPA1 c. MFN1 493 
and d. Drp1 mRNA levels were determined by realtime RT-PCR. *** P<0.005 indicates 494 
statistically significant difference relative to medium.  495 
Figure 6. Overexpression of GLO1 enhanced mitochondrial fusion key proteins’ 496 
expression. a. GLO1 activity was determined, the detail method was described in Materials and 497 
Methods. ** P<0.01 indicates statistically significant difference relative to transfection with 498 
pcDNA. ## P<0.01 indicates statistically significant difference related to MGO cultured BRECs, 499 
which were transfected with pcDNA. b. Cell viability was determined by crystal violet assay. *** 500 
P<0.005 indicates statistically difference related to BRECs transfected with pcDNA. # P<0.05 501 
indicates statistically difference related to MGO cultured BRECs transfected with pcDNA. c. 502 
OPA1 and d. MFN1 mRNA levels were determined by realtime RT-PCR. ***P<0.005 indicates 503 
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statistically significant difference relative to BRECs transfected with pcDNA. # P<0.05 indicates 504 
statistically difference related to MGO cultured BRECs transfected with pcDNA.  505 
Figure 7. Inhibition of GLO1 by siRNA abolished the effect of Tan IIa on cellular reactive 506 
oxygen species formation and mitochondrial fusion proteins expression. a. GLO1 mRNA 507 
levels were determined by realtime RT-PCR. ** P<0.01, ***P<0.005 indicates statistically 508 
significant difference relative to scramble siRNA. # P<0.05, ### P<0.005 indicates statistically 509 
significant difference relative to 100 µM MGO treated BRECs transfected with scramble siRNA. 510 
$ P<0.05 indicates statistically significant difference relative to 100 µM MGO and 50 µM Tan IIa 511 
treated BRECs transfected with scramble siRNA. b. Cellular reactive oxygen species level was 512 
determined by CM-H2DCFDA. **P<0.01, *** P<0.005 indicates statistically difference related to 513 
MGO and scramble siRNA, ## P<0.01 indicates statistically significant difference relative to 514 
MGO treated BRECs transfected with scramble siRNA. $ P<0.05 indicates statistically 515 
significant difference relative to 100 µM MGO and 50 µM Tan IIa treated BRECs transfected 516 
with scramble siRNA. c. OPA1 and d. MFN1 mRNA levels were determined by realtime RT-517 
PCR. ** P<0.01 indicates statistically significant difference relative to scramble siRNA. ## 518 
P<0.01 indicates statistically significant difference relative to 100 µM MGO treated BRECs 519 
transfected with scramble siRNA. $ P<0.05 indicates statistically significant difference relative to 520 
100 µM MGO and 50 µM Tan IIa treated BRECs transfected with scramble siRNA. 521 
 522 
Supplemental figure 523 
Figure Glycated site prediction in OPA1 and MFN1. Potential glycated sites in A. OPA1 B. 524 
MFN1 was analyzed using http://www.cbs.dtu.dk/services/NetGlycate/. Screenshot of analysis 525 
indicated OPA1 and MFN1 might be glycated.526 
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